Quoin Pharmaceuticals Announces Acceptance of QRX003 Paper in Dermatology and Therapy
Quoin Pharmaceuticals announced the acceptance of a peer-reviewed paper introducing QRX003, an investigational topical lotion for Netherton Syndrome, in Dermatology and Therapy. The paper details the drug's mechanism, a positive pediatric compassionate use case by Professor Alan Irvine, and promising interim Phase 2/3 study results showing clinical…